Arcadis negotiating exclusive licence for PFAS technology

Built and natural asset design and management company Arcadis has signed a heads of agreement and entered into an exclusive commercial negotiation for sole rights to Evocra’s PFAS solutions technology.

The technology is a welcome addition to Arcadis’s existing suite of PFAS solutions, allowing Arcadis to continue to offer a differentiated solution for clients globally.

PFAS, or per- and poly-fluorinated alkyl substances, were historically incorporated in commercial, industrial and consumer products including textile coatings, stain repellents, electronics, mist suppressants and firefighting foams known as aqueous film-forming foam (AFFF).

Under increasing scientific and regulatory scrutiny and community awareness, we have a better understanding of PFAS toxicity, environmental persistence, aquifer mobility and the potential for this emerging contaminant to bioaccumulate in natural environments and enter the food chain.

Australian-based water treatment company Evocra has a patented technology that uses ozone fractionation to separate and concentrate PFAS from impacted media. This process has demonstrated commercial-scale ability to remove PFAS and deliver an output that meets stringent discharge requirements set by regulators and other relevant authorities.

Arcadis is at the forefront of a global effort to remove PFAS from impacted sites and environments, with over 75 projects in its portfolio, representing over 300 individual sites in 12 countries. This deal will continue Arcadis’s push to achieve greater market share within the PFAS space and provide clients with an innovative solution that can be used on its own and/or in conjunction with other technologies to remove PFAS from impacted sources.

“Evocra and their treatment process provides our clients with an innovative solution to cost-effectively remove a complex contaminant from their assets and improve our environment,” Arcadis CEO Australia Pacific Malcolm McDowall said.

“When the Evocra technology is coupled with either Arcadis-developed or other commercially available destructive technologies, we will have the ability to offer our clients a zero-waste outcome.”

The ozone fractionation used by Evocra has benefits over other separation and/or adsorption technologies, particularly for liquids that have high concentrations of PFAS and for complex waste streams with multiple contaminants.

Image credit: ©stock.adobe.com/au/amenic 181